Literature DB >> 3444393

In vitro and in vivo cytotoxicity of alkyl lysophospholipid ET-18-OCH3 and thioether lipid BM 41.440.

G H Leder1, H H Fiebig, E Wallbrecher, B R Winterhalter, G W Löhr.   

Abstract

Screening for cytotoxicity in the clonogenic assay in human tumor xenografts and L1210 mouse leukemia revealed comparable dose-dependent effects of the alkyl lysophospholipid ET-18-OCH3 and the thioether lipid BM 41.440. The efficacy in human tumors only was marginal at low doses. In vivo tests of both agents were carried out in nude mice bearing two of the tumors that proved most sensitive in vitro and in mice inoculated with L1210 leukemia. Only small effects on the growth of the human tumors and no effects on L1210 leukemia were observed. In view of clinical rules for definition of remission, no convincing antitumor effects were obtained.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3444393     DOI: 10.1007/BF02535564

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

1.  Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.

Authors:  A Goldin; J M Venditti; J S Macdonald; F M Muggia; J E Henney; V T Devita
Journal:  Eur J Cancer       Date:  1981-02       Impact factor: 9.162

2.  Development of three human small cell lung cancer models in nude mice.

Authors:  H H Fiebig; H A Neumann; H Henss; H Koch; D Kaiser; H Arnold
Journal:  Recent Results Cancer Res       Date:  1985

Review 3.  Anti-tumor action of alkyl-lysophospholipids (Review).

Authors:  W E Berdel; W R Bausert; U Fink; J Rastetter; P G Munder
Journal:  Anticancer Res       Date:  1981       Impact factor: 2.480

4.  Influence of the alkyllysophospholipid ET-18-OCH3 on methylnitrosourea-induced rat mammary carcinomas.

Authors:  M R Berger; P G Munder; D Schmähl; O Westphal
Journal:  Oncology       Date:  1984       Impact factor: 2.935

5.  Destruction of human solid tumors by alkyl lysophospholipids.

Authors:  M H Runge; R Andreesen; A Pfleiderer; P G Munder
Journal:  J Natl Cancer Inst       Date:  1980-06       Impact factor: 13.506

6.  Treatment of autochthonous rat colonic adenocarcinomas with a thioether-lysophospholipid derivative in mono- and combination chemotherapy.

Authors:  M E Heim; M Swoboda; W Pahlke; L Edler; U Bicker
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

7.  Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development.

Authors:  H H Fiebig; J R Schmid; W Bieser; H Henss; G W Lohr
Journal:  Eur J Cancer Clin Oncol       Date:  1987-07

8.  Application of a human tumor colony-forming assay to new drug screening.

Authors:  R H Shoemaker; M K Wolpert-DeFilippes; D H Kern; M M Lieber; R W Makuch; N R Melnick; W T Miller; S E Salmon; R M Simon; J M Venditti
Journal:  Cancer Res       Date:  1985-05       Impact factor: 12.701

9.  Potentials and drawbacks of the human tumor stem cell assay.

Authors:  R H Shoemaker; M K Wolpert-DeFilippes; J M Venditti
Journal:  Behring Inst Mitt       Date:  1984-05

10.  Comparison of tumor response in nude mice and in the patients.

Authors:  H H Fiebig; C Schuchhardt; H Henss; L Fiedler; G W Löhr
Journal:  Behring Inst Mitt       Date:  1984-05
View more
  3 in total

1.  Antineoplastic activity of alkylphosphocholines (APC) in human breast carcinomas in vivo and in vitro; use of liposomes.

Authors:  I Fichtner; R Zeisig; H Naundorf; S Jungmann; D Arndt; G Asongwe; J A Double; M C Bibby
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 2.  Membrane-interactive lipids as experimental anticancer drugs.

Authors:  W E Berdel
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

3.  Effects of iron supplementation and ET-18-OCH3 on MDA-MB 231 breast carcinomas in nude mice consuming a fish oil diet.

Authors:  W E Hardman; C J Barnes; C W Knight; I L Cameron
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.